HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
1.450
-0.180 (-11.04%)
At close: Jun 8, 2026, 4:00 PM EDT
1.350
-0.100 (-6.90%)
After-hours: Jun 8, 2026, 7:59 PM EDT
HCW Biologics Market Cap
HCW Biologics has a market cap or net worth of $10.38 million as of June 8, 2026. Its market cap has decreased by -26.16% in one year.
Market Cap
10.38M
Enterprise Value
15.73M
1-Year Change
-26.16%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on July 20, 2021, HCW Biologics's market cap has decreased from $285.20M to $10.38M, a decrease of -96.36%. That is a compound annual growth rate of -49.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 11.67M | 345.15% |
| Dec 31, 2025 | 2.62M | -86.80% |
| Dec 31, 2024 | 19.87M | -54.91% |
| Dec 29, 2023 | 44.07M | -35.84% |
| Dec 30, 2022 | 68.69M | -17.13% |
| Dec 31, 2021 | 82.89M | -70.94% |
| Jul 20, 2021 | 285.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 12.81M |
| Chemomab Therapeutics | 12.74M |
| Cyclerion Therapeutics | 12.64M |
| Phio Pharmaceuticals | 12.31M |
| BioVie | 12.07M |
| SeaStar Medical Holding | 11.82M |
| BioCardia | 11.72M |
| Theriva Biologics | 11.71M |